This website is being migrated. In case you don't find the information you are looking for, the old website can be found here. Thank you for reporting any anomalies to communication@ill.eu.

News

AdobeStock_740970312.jpeg
Sept. 24, 2024 Licensed To Kill (Bacteria): Fatty Acids against Antibiotic-Resistant Germs
An interdisciplinary team of researchers has established a set of conditions under which sustainable fatty acid complexes can efficiently fight against dangerous, antibiotic-resistant bacteria. The results are encouraging and inspire further research on the development of fatty acid-based antibiotics. They further demonstrate the value of neutron scattering in this kind of pharmaceutical research.
20240701 AntimicrobialPeptides LPorcar AdobeStock_98515861.jpeg
Aug. 7, 2024 Neutrons reveal surprises about the action of natural antibiotics
Antimicrobial peptides (AMPs) are natural antibiotics which are very effective against resistant bacteria. Despite their interesting properties, AMPs remain difficult to use. A study just published marks a remarkable step forward in understanding how AMPs work. Taking full advantage of neutron and X-ray scattering, researchers obtained results that are both important and surprising.
240723_ Peptoid_peptid_hydrogels_ _cover_ _AdobeStock_882758409.jpeg
July 23, 2024 Exciting new material for long-acting drug delivery
HIV/AIDS remains a major global health challenge, with an estimated 39 million people living with the disease and 1.5 million new infections each year. Though antiretroviral therapy provides effective treatment and prevention, limitations arise due to inadequate adherence to the required lifelong daily drug regimen. There is thus significant interest in the development of long-acting drug delivery systems that enable consistent and sustained drug release for extended periods. Researchers from Queen’s University Belfast have recently published proof-of-concept of a long-acting drug delivery platform based on a novel peptoid-peptide material. The contribution to this work by the Institut Laue-Langevin (ILL) demonstrates, once again, the facility’s dedication to the provision of neutrons for society.